chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Heart rate irregular, SARS-CoV-2 test positive
Clinical narrative: I tested positive for Covid-19; I had ringing in my ears I lost my taste and smell still to this day I cant taste and smell also my pulse rate is irregular.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: I tested positive for Covid-19; I had ringing in my ears I lost my taste and smell still to this day I cant taste and smell also my pulse rate is irregular.
Age: 54.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days after beyond use date.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Incorrect product formulation administered, Pain in extremity
Clinical narrative: Pt requested Pfizer COVID bivalent vaccine but was given Pfizer COVID monovalent vaccine in error due to provide moving quickly and not double-checking label.  Pt did report sore arm and "feeling crappy" for the following day but otherwise no other adverse effects.
Age: 17.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Disorientation, Dizziness, Muscular weakness, Pallor, Speech disorder
Clinical narrative: INITIAL VACCINE ADMINISTRATION, PT WAS DOING OK. PT REMAINED SITTING, NO CONCERNS NOTED.  SMALL CONVERSATION WITH PT WAS MADE, PT WAS SMILING. EDUCATED PT ON COMFORT MEASURES AFTER INJECTION, POSSIBLE PAIN FROM INJECTION, ENCOURAGED COMFORT MEASURES TO PERFORM AT HOME. PT AND MOTHER AGREED. PT REMAINED SITTING FOR APROXIMATELY 7-8 MORE MIN AND EXPRESS SHE WAS FEELING FINE. PT AND MOTHER WAS PROCEEDING TO CHECK OUT. PT WAS AGAIN ASKED HOW SHE WAS DOING, PT STATED SHE WAS FINE. HER AND HER MOTHER CONTINUED TO WALK AWAY. I DECIDED TO FOLLOW PT TO CHECK OUT DESK AND THAT IS WHEN I SEEN HER TURN TO HER MOTHER AND STATE SHE WAS FEELING DIZZY, PT THEN GOT SHAKEY, HER LEGS STARTED TO BUCKLE UNDER HER, I IMMEDIATELY GRABBED HER ALONG WITH HER MOTHER AND DIRECTED HER TO A CHAIR NEAR BY. MOTHER WAS INSTRUCTED TO STAY NEXT TO HER SIDE, I PROCEDED TO GET THE PROVIDER AND ADVISE HER WHAT WAS HAPPENING. PROVIDER AND MOTHER WERE NEAR PT, I GOT A GLASS OF WATER, ORANGE JUICE AND A WET TOWEL. RETURNED TO PT AND PROVIDER WAS FANNING HER, MOTHER NEAR. PT WAS VERY PALE, DISORIENTED AND RAMBLING HER SPEACH. PT DID NOT LOOSE CONSCIOUSNESS. PT WAS INSTRUCTED TO DRINK SOME WATER, WE KEPT HER TALKING, THE COLD WET TOWEL WAS PLACED AROUND HER NECK. PT CONTINUED TO HAVE SOME SHAKIENESS BUT WAS SLOWLY RECOVERING. PROVIDER KEPT TALKING TO HER. PT WAS GIVEN SOME ORANGE JUICE. APROXIMATELY 10 MIN PT HAD RECOVERED, SHE WAS SLIGHTY SHAKY AND WHEN SHE SPOKE SHE MADE SENSE. PT WAS NO LONGER PALE AND REMAINED SITTING FOR APROX ANOTHER 5 MIN. PT REQUESTED TO LEAVE, INSTRUCTED HER TO STAND UP . PT REPORTED FEELING MUCH BETTER AND WANTED TO LEAVE WITH HER MOTHER. PROVIDER WALKED WITH PT AND MOTHER TO HER VEHICLE, NO FURTHER CONCERNS NOTED.
Age: 17.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Tremor
Clinical narrative: INITIAL VACCINE ADMINISTRATION, PT WAS DOING OK. PT REMAINED SITTING, NO CONCERNS NOTED.  SMALL CONVERSATION WITH PT WAS MADE, PT WAS SMILING. EDUCATED PT ON COMFORT MEASURES AFTER INJECTION, POSSIBLE PAIN FROM INJECTION, ENCOURAGED COMFORT MEASURES TO PERFORM AT HOME. PT AND MOTHER AGREED. PT REMAINED SITTING FOR APROXIMATELY 7-8 MORE MIN AND EXPRESS SHE WAS FEELING FINE. PT AND MOTHER WAS PROCEEDING TO CHECK OUT. PT WAS AGAIN ASKED HOW SHE WAS DOING, PT STATED SHE WAS FINE. HER AND HER MOTHER CONTINUED TO WALK AWAY. I DECIDED TO FOLLOW PT TO CHECK OUT DESK AND THAT IS WHEN I SEEN HER TURN TO HER MOTHER AND STATE SHE WAS FEELING DIZZY, PT THEN GOT SHAKEY, HER LEGS STARTED TO BUCKLE UNDER HER, I IMMEDIATELY GRABBED HER ALONG WITH HER MOTHER AND DIRECTED HER TO A CHAIR NEAR BY. MOTHER WAS INSTRUCTED TO STAY NEXT TO HER SIDE, I PROCEDED TO GET THE PROVIDER AND ADVISE HER WHAT WAS HAPPENING. PROVIDER AND MOTHER WERE NEAR PT, I GOT A GLASS OF WATER, ORANGE JUICE AND A WET TOWEL. RETURNED TO PT AND PROVIDER WAS FANNING HER, MOTHER NEAR. PT WAS VERY PALE, DISORIENTED AND RAMBLING HER SPEACH. PT DID NOT LOOSE CONSCIOUSNESS. PT WAS INSTRUCTED TO DRINK SOME WATER, WE KEPT HER TALKING, THE COLD WET TOWEL WAS PLACED AROUND HER NECK. PT CONTINUED TO HAVE SOME SHAKIENESS BUT WAS SLOWLY RECOVERING. PROVIDER KEPT TALKING TO HER. PT WAS GIVEN SOME ORANGE JUICE. APROXIMATELY 10 MIN PT HAD RECOVERED, SHE WAS SLIGHTY SHAKY AND WHEN SHE SPOKE SHE MADE SENSE. PT WAS NO LONGER PALE AND REMAINED SITTING FOR APROX ANOTHER 5 MIN. PT REQUESTED TO LEAVE, INSTRUCTED HER TO STAND UP . PT REPORTED FEELING MUCH BETTER AND WANTED TO LEAVE WITH HER MOTHER. PROVIDER WALKED WITH PT AND MOTHER TO HER VEHICLE, NO FURTHER CONCERNS NOTED.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Paraesthesia oral
Clinical narrative: Employee began to c/o strange feeling on the R side of her tongue.  She continued to report the feeling was spreading to the back of her tongue.   Employee was immediately taken to ER by Employee Health Nurse
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: The correct vaccine was administered but it was past its Beyond Use Date of 11-17-2022.  Patient was notified and has not experienced any trouble.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: patient states that arm is still sore since immunization on 11/17
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was given 16 days after beyond use date.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine was given 16 days after beyond use date.
Age: 1.5
Sex: M
Vaccine: COVID19, FLUC4, HEPA
Symptoms: Capillary nail refill test, Pallor, Pruritus, Pyrexia, Rash
Clinical narrative: Pt brought in by mom and grma. A few red dots noticed on arms and face at bedtime on 11/7/22. Woke with much more rash in AM of 12/8/22, with most dense rash on face. No new known evironmental exposures.  Pt with pruritis of scalp and posterior neck. No SOB, no lip swelling, no diarrhea.  Tactile fevers at home. Temp 99.0F here in clinic.  On exam he is scratching his scalp.  No facial swelling. Mucous membrans moist.  Lungs clear, no wheezing. Heart RRR w/o murmurs. Cap refill < 1 sec.  Injection sites on deltoids w/o redness, tenderness or swelling. Starting in the upper leg and groin area he has a blanching macular papular red slightly raised rash that becomes more confluent the closer you get to his scalp and face where it is mostly confluent.  No vesicles or ulcers.  No petechiae. Pt had a Biofire nasopharyngeal swab done and was prescribed oral diphenhydramine for the pruritis and acetaminophen suppositories to replace the liquid form with f/u as needed.  Despite the negative NP swab I  do think it is more likely this is a viral exanthem rash, but because I can't find a pathogen, I am reporting this to VAERS.
Age: 1.5
Sex: M
Vaccine: COVID19, FLUC4, HEPA
Symptoms: Rash erythematous, Rash macular, Rash papular, Respiratory pathogen panel, Viral rash
Clinical narrative: Pt brought in by mom and grma. A few red dots noticed on arms and face at bedtime on 11/7/22. Woke with much more rash in AM of 12/8/22, with most dense rash on face. No new known evironmental exposures.  Pt with pruritis of scalp and posterior neck. No SOB, no lip swelling, no diarrhea.  Tactile fevers at home. Temp 99.0F here in clinic.  On exam he is scratching his scalp.  No facial swelling. Mucous membrans moist.  Lungs clear, no wheezing. Heart RRR w/o murmurs. Cap refill < 1 sec.  Injection sites on deltoids w/o redness, tenderness or swelling. Starting in the upper leg and groin area he has a blanching macular papular red slightly raised rash that becomes more confluent the closer you get to his scalp and face where it is mostly confluent.  No vesicles or ulcers.  No petechiae. Pt had a Biofire nasopharyngeal swab done and was prescribed oral diphenhydramine for the pruritis and acetaminophen suppositories to replace the liquid form with f/u as needed.  Despite the negative NP swab I  do think it is more likely this is a viral exanthem rash, but because I can't find a pathogen, I am reporting this to VAERS.
Age: 45.0
Sex: F
Vaccine: FLUR4
Symptoms: Dizziness
Clinical narrative: dizziness
Age: 0.5
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: No adverse event but they gave her the wrong dose. They gave her .5 when she is only 6 months old. She should of received .2 of the moderna. She took twice as much for the first dose. I don't know if they reported this or where to report this.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ageusia, Anosmia, Arthralgia, Asthenia, Cough
Clinical narrative: I had joint pains a couple days after vaccination. On 11/29/2022 I got this horrible infection. I had sinus pain and pressure, severe headache, and sinus congestion. I am a physician, so I cured myself and I took an antibiotic. I had blood coming out of my nose with phlegm and a cough. I was feeling weak and no energy for 4-5 days. I also lost smell and taste. I took two COVID-19 tests and they were negative.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Epistaxis, Headache, Infection, Paranasal sinus discomfort, Productive cough
Clinical narrative: I had joint pains a couple days after vaccination. On 11/29/2022 I got this horrible infection. I had sinus pain and pressure, severe headache, and sinus congestion. I am a physician, so I cured myself and I took an antibiotic. I had blood coming out of my nose with phlegm and a cough. I was feeling weak and no energy for 4-5 days. I also lost smell and taste. I took two COVID-19 tests and they were negative.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test negative, Sinus congestion, Sinus pain
Clinical narrative: I had joint pains a couple days after vaccination. On 11/29/2022 I got this horrible infection. I had sinus pain and pressure, severe headache, and sinus congestion. I am a physician, so I cured myself and I took an antibiotic. I had blood coming out of my nose with phlegm and a cough. I was feeling weak and no energy for 4-5 days. I also lost smell and taste. I took two COVID-19 tests and they were negative.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Crying, Headache, Pain in extremity, Sleep disorder
Clinical narrative: Moderna Bivalent Booster 11am, Aleve 220mg at 12pm, Aleve 220mg 10pm (bedtime).  Woke up crying at 2:35am, severe joint pain in majority of limb joints - ankles, knees, hips, shoulders, elbows, wrists, fingers.  Took Aleve 220mg 2:45am monday (because of the severe pain), Keterolac 10mg at 4:15am, Tylenol 1000mg (2x500mg) 7am (lessened pain 9-10 and I slept some), Tylenol 1000mg at 11am, slept a bit from 12:30-1:30ish, Tylenol 1000mg at 3pm, intermittent sleep between 4 and 6, Tylenol 1000mg at 6pm (joint pain lessened but increasing, and headache).  I have had kidney stones and this pain was so intense and long lasting (16 hours with three brief reprieves) that it competed for space on my most painful conditions list.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Headache, Influenza virus test positive, Nasal congestion, Oropharyngeal pain
Clinical narrative: I developed a sore throat with headache, a low-grade fever of 102.2. I also had sinus drainage and congestion. I went to the doctor on Tuesday morning and was tested for COVID-19 and flu. I was given a prescription for PAXLOVID, and they suggested TYLENOL for any pain and MUCINEX for drainage. My symptoms improved. I still have a little bit of cough with nasal congestion and stuffiness.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sinus congestion, Sinus disorder
Clinical narrative: I developed a sore throat with headache, a low-grade fever of 102.2. I also had sinus drainage and congestion. I went to the doctor on Tuesday morning and was tested for COVID-19 and flu. I was given a prescription for PAXLOVID, and they suggested TYLENOL for any pain and MUCINEX for drainage. My symptoms improved. I still have a little bit of cough with nasal congestion and stuffiness.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Death, Illness, SARS-CoV-2 test positive, Urine analysis
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 02/24/2021, 03/24/2021, and 12/01/2021. They tested positive for COVID-19 on 09/03/2022. It appears they were hospitalized for the illness (the import of the lab report indicates hospital admission) but I do not have a discharge date available.  I can see they had a urine sample sent to a lab on 09/22/2022. The individual died on 10/05/2022.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 02/24/2021, 03/24/2021, and 12/01/2021. They tested positive for COVID-19 on 09/03/2022. It appears they were hospitalized for the illness (the import of the lab report indicates hospital admission) but I do not have a discharge date available.  I can see they had a urine sample sent to a lab on 09/22/2022. The individual died on 10/05/2022.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Hypoglycaemia, Influenza virus test negative, Loss of consciousness, Pyrexia
Clinical narrative: My adverse event started on 11/26/2022 at night around 8:00AM. I started coughing, yellow drainage in my nose. On Saturday morning I had fever and cough. I went to the urgent care on Sunday morning. I passed out in the bathroom. They diagnosed me with Syncope Hypoglycemia. I tested negative for flu and COVID-19. I was positive for RSV. In the urgent care they gave me IV with fluids to hydrate me. They also prescribed me with benzoate 10 mg 3 times per day.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory syncytial virus test positive, Rhinorrhoea, SARS-CoV-2 test negative, Syncope
Clinical narrative: My adverse event started on 11/26/2022 at night around 8:00AM. I started coughing, yellow drainage in my nose. On Saturday morning I had fever and cough. I went to the urgent care on Sunday morning. I passed out in the bathroom. They diagnosed me with Syncope Hypoglycemia. I tested negative for flu and COVID-19. I was positive for RSV. In the urgent care they gave me IV with fluids to hydrate me. They also prescribed me with benzoate 10 mg 3 times per day.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Impaired work ability, Incorrect product formulation administered, Malaise
Clinical narrative: Patient presented to clinic to receive Shingles vaccine and was administered COVID Bivalent Booster instead. Patient had already received this booster on 10/4/22 so received two bivalent boosters. Patient did experience ill feelings the day after the vaccination and did have to leave work. Resolved by the following day.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Inappropriate schedule of product administration, Product administered to patient of inappropriate age, Vaccination error
Clinical narrative: PATIENT WAS NEVER STARTED ON THE ROTAVIRUS SERIES AND DURING HER 6 MONTHS PHYSICAL SCHEDULED ON 12/7/2022, SHE WAS GIVEN THE ROTAVIRUS(ROTATEQ) VACCINE FOR THE FIRST TIME IN ERROR. ROTAVIRUS IS NOT RECOMMENED AFTER THE AGE OF  15 WEEKS.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Epistaxis, Influenza virus test negative, Malaise, Paranasal sinus discomfort, SARS-CoV-2 test negative
Clinical narrative: I had a raw throat, sinus pressure, and was just feeling unwell. Saturday, I felt like I was getting worse and was having nose bleeds. That is when I decided to go to the doctor. They gave me a Dexamethasone Steroid injection. I was prescribed Doxycycline Monohydrate, and Benzonatate. I am feeling better, but I still have some of the symptoms.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Streptococcus test negative, Throat irritation
Clinical narrative: I had a raw throat, sinus pressure, and was just feeling unwell. Saturday, I felt like I was getting worse and was having nose bleeds. That is when I decided to go to the doctor. They gave me a Dexamethasone Steroid injection. I was prescribed Doxycycline Monohydrate, and Benzonatate. I am feeling better, but I still have some of the symptoms.
Age: 0.17
Sex: M
Vaccine: RV1
Symptoms: Intussusception, Ultrasound scan abnormal
Clinical narrative: Intussusception
Age: 15.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Fall
Clinical narrative: Claimant alleges she received the vaccine at the pharmacy and began feeling dizzy and fell to the ground while in the waiting area.
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Chills, Fatigue, Feeling abnormal, Hyperhidrosis, Pain
Clinical narrative: fatigue and fever began initially, felt he was coming down with something by 6pm. He felt "bad by 7pm".  He felt, "achy and painful to move". Was in bed by 10pm and had tried using heating pad as he felt, "severe chills, body aches, and sweating". He remained in bed until 10am the following morning. He still felt sore the following day
Age: 73.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Pyrexia
Clinical narrative: fatigue and fever began initially, felt he was coming down with something by 6pm. He felt "bad by 7pm".  He felt, "achy and painful to move". Was in bed by 10pm and had tried using heating pad as he felt, "severe chills, body aches, and sweating". He remained in bed until 10am the following morning. He still felt sore the following day
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, COVID-19, Chest pain, Cough
Clinical narrative: I received the Pfizer COVID-19 booster on 5/31/2022. On 8/31/2022, I developed a sore throat, post-nasal drip, joint pain, and fatigue. I pretty much felt like I had strep throat. The joint pain that I had was different from the joint pain I normally get when I have the flu. Whenever I get the flu, I get joint pain in my spine, but on 8/31/2022, I had joint pain in my shoulders, my hips, and across the upper portion of my chest. However, I didn't experience any pain in the spinal area. I took a home antigen test and got a positive result that day. I then called the doctor's office and got a prescription for PAXLOVID. I obtained the PAXLOVID on 9/1/2022 and began taking it at 3PM that day. On that day, I had a low-grade fever, pain in both ears, and a mild cough. I continued taking the medication as prescribed; while I took the PAXLOVID, I had to stop taking SYMBICORT and FLONASE on account of contraindications. The first 2 days of my illness were the worst. I felt lethargic and my cough got worse as time went on. I continued to run an intermittent low-grade fever. I still tested positive as of 9/10/2022. On 9/16/2022, I had mushy diarrhea. On 9/17/2022, I had yellowish liquid diarrhea. The cold-like symptoms resolved pretty quickly, but the fatigue, brain fog, and vertigo lingered. When I stopped taking the SYMBICORT and FLONASE, there happened to be forest fires in our area. I had an asthma attack that was likely triggered by the smoke from the forest fires, but it also may have been exacerbated by the COVID-19. Whenever I have an asthma attack, I always get a severe cough that lingers for weeks. The cough that I developed from this attack lasted until sometime in October 2022. On 9/18/2022, I took a home antigen test and got a negative response. I've recovered from most of the symptoms, but the time of this writing, I continue to deal with vertigo, brain fog, and fatigue.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Ear pain, Faeces discoloured, Fatigue, Feeling abnormal
Clinical narrative: I received the Pfizer COVID-19 booster on 5/31/2022. On 8/31/2022, I developed a sore throat, post-nasal drip, joint pain, and fatigue. I pretty much felt like I had strep throat. The joint pain that I had was different from the joint pain I normally get when I have the flu. Whenever I get the flu, I get joint pain in my spine, but on 8/31/2022, I had joint pain in my shoulders, my hips, and across the upper portion of my chest. However, I didn't experience any pain in the spinal area. I took a home antigen test and got a positive result that day. I then called the doctor's office and got a prescription for PAXLOVID. I obtained the PAXLOVID on 9/1/2022 and began taking it at 3PM that day. On that day, I had a low-grade fever, pain in both ears, and a mild cough. I continued taking the medication as prescribed; while I took the PAXLOVID, I had to stop taking SYMBICORT and FLONASE on account of contraindications. The first 2 days of my illness were the worst. I felt lethargic and my cough got worse as time went on. I continued to run an intermittent low-grade fever. I still tested positive as of 9/10/2022. On 9/16/2022, I had mushy diarrhea. On 9/17/2022, I had yellowish liquid diarrhea. The cold-like symptoms resolved pretty quickly, but the fatigue, brain fog, and vertigo lingered. When I stopped taking the SYMBICORT and FLONASE, there happened to be forest fires in our area. I had an asthma attack that was likely triggered by the smoke from the forest fires, but it also may have been exacerbated by the COVID-19. Whenever I have an asthma attack, I always get a severe cough that lingers for weeks. The cough that I developed from this attack lasted until sometime in October 2022. On 9/18/2022, I took a home antigen test and got a negative response. I've recovered from most of the symptoms, but the time of this writing, I continue to deal with vertigo, brain fog, and fatigue.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: I received the Pfizer COVID-19 booster on 5/31/2022. On 8/31/2022, I developed a sore throat, post-nasal drip, joint pain, and fatigue. I pretty much felt like I had strep throat. The joint pain that I had was different from the joint pain I normally get when I have the flu. Whenever I get the flu, I get joint pain in my spine, but on 8/31/2022, I had joint pain in my shoulders, my hips, and across the upper portion of my chest. However, I didn't experience any pain in the spinal area. I took a home antigen test and got a positive result that day. I then called the doctor's office and got a prescription for PAXLOVID. I obtained the PAXLOVID on 9/1/2022 and began taking it at 3PM that day. On that day, I had a low-grade fever, pain in both ears, and a mild cough. I continued taking the medication as prescribed; while I took the PAXLOVID, I had to stop taking SYMBICORT and FLONASE on account of contraindications. The first 2 days of my illness were the worst. I felt lethargic and my cough got worse as time went on. I continued to run an intermittent low-grade fever. I still tested positive as of 9/10/2022. On 9/16/2022, I had mushy diarrhea. On 9/17/2022, I had yellowish liquid diarrhea. The cold-like symptoms resolved pretty quickly, but the fatigue, brain fog, and vertigo lingered. When I stopped taking the SYMBICORT and FLONASE, there happened to be forest fires in our area. I had an asthma attack that was likely triggered by the smoke from the forest fires, but it also may have been exacerbated by the COVID-19. Whenever I have an asthma attack, I always get a severe cough that lingers for weeks. The cough that I developed from this attack lasted until sometime in October 2022. On 9/18/2022, I took a home antigen test and got a negative response. I've recovered from most of the symptoms, but the time of this writing, I continue to deal with vertigo, brain fog, and fatigue.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: I received the Pfizer COVID-19 booster on 5/31/2022. On 8/31/2022, I developed a sore throat, post-nasal drip, joint pain, and fatigue. I pretty much felt like I had strep throat. The joint pain that I had was different from the joint pain I normally get when I have the flu. Whenever I get the flu, I get joint pain in my spine, but on 8/31/2022, I had joint pain in my shoulders, my hips, and across the upper portion of my chest. However, I didn't experience any pain in the spinal area. I took a home antigen test and got a positive result that day. I then called the doctor's office and got a prescription for PAXLOVID. I obtained the PAXLOVID on 9/1/2022 and began taking it at 3PM that day. On that day, I had a low-grade fever, pain in both ears, and a mild cough. I continued taking the medication as prescribed; while I took the PAXLOVID, I had to stop taking SYMBICORT and FLONASE on account of contraindications. The first 2 days of my illness were the worst. I felt lethargic and my cough got worse as time went on. I continued to run an intermittent low-grade fever. I still tested positive as of 9/10/2022. On 9/16/2022, I had mushy diarrhea. On 9/17/2022, I had yellowish liquid diarrhea. The cold-like symptoms resolved pretty quickly, but the fatigue, brain fog, and vertigo lingered. When I stopped taking the SYMBICORT and FLONASE, there happened to be forest fires in our area. I had an asthma attack that was likely triggered by the smoke from the forest fires, but it also may have been exacerbated by the COVID-19. Whenever I have an asthma attack, I always get a severe cough that lingers for weeks. The cough that I developed from this attack lasted until sometime in October 2022. On 9/18/2022, I took a home antigen test and got a negative response. I've recovered from most of the symptoms, but the time of this writing, I continue to deal with vertigo, brain fog, and fatigue.
Age: 33.0
Sex: F
Vaccine: HEP
Symptoms: Injection site rash, Injection site reaction, Rash papular
Clinical narrative: Localized raised red bumps at site of injection and more on opposite deltoid
Age: 90.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 98.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/28/2021, 02/25/2021, and 07/12/2022. They also received the Pfizer Bivalent product on 10/11/2022. They tested positive for COVID-19 on 09/15/2022. They received home care from a hospital system from 10/14/2022 until their death on 10/20/2022. Also note this person received their last booster about 8 days before their death. COVID-19 disease is on the death certificate.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram, Dizziness, Dyspnoea, Dyspnoea exertional
Clinical narrative: Shortness of Breath (SOB) started May 2022; August 2022 symptoms got steadily worse; October & November 2022 SOB was severe upon simple exertion as well as lightheadedess;  Referred to Cardiologist with first visit on November 30, 2022; Scheduled for Nucler Stress Test, etc. on December 19, 2022.   Have 3 extremely serious episodes of SOB with severe chest pain:   12/03/2022, 12/04/2022 and 12/06/2022.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary function test
Clinical narrative: Shortness of Breath (SOB) started May 2022; August 2022 symptoms got steadily worse; October & November 2022 SOB was severe upon simple exertion as well as lightheadedess;  Referred to Cardiologist with first visit on November 30, 2022; Scheduled for Nucler Stress Test, etc. on December 19, 2022.   Have 3 extremely serious episodes of SOB with severe chest pain:   12/03/2022, 12/04/2022 and 12/06/2022.
Age: 8.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Urticaria
Clinical narrative: Pt received covid vaccine at 3pm, then flu shot 5 minutes later, then 5 minutes after that had hives on face, chest, and neck. hives began improving 15 minutes later on face, but still has hives on chest and neck.
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Pfizer Bivalent was administered but after the Beyond Use Date
Age: 46.0
Sex: M
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: no adverse reaction, vaccine was given to pt after age of 45 and was given to early for interval of 2nd and 3rd dose
Age: 13.0
Sex: F
Vaccine: IPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Due to confusing way in which the expiration date is listed on box and vial 25 July 22 the patient received an expired dose of vaccine.  There was no adverse effect and the vaccine was scheduled to be regiven.
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: N/A. NO ADVERSE EVENT TO VACCINE. VACCINE OUTSIDE OF STORAGE REQUIREMENTS. REVACCINATION RECOMMENDED.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days beyond use date
Age: 81.0
Sex: M
Vaccine: COVID19-2, UNK
Symptoms: Dizziness, Paraesthesia, Paraesthesia oral
Clinical narrative: Paresthesia - simultaneously occurring:  mild tingling of right side of upper lip, tingling of right side of neck, some tingling of right arm, and severe tingling of entire right hand-all fingers and entire hand.  Occurs usually once daily and up to six times daily, lasting from a minute to 5-10 minutes, regardless of arm position or activity.  At the same time there is a lightheaded sensation.  Never had this before.  No trauma or injury to the neck or right arm.  No rash.
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer Bivalent was administered after the Beyond Use Date
Age: 19.0
Sex: F
Vaccine: IPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Due to confusing way in which the expiration date is listed on box and vial 25 July 22 the patient received an expired dose of vaccine.  There was no adverse effect and the vaccine was scheduled to be regiven.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days beyond use date
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Electrocardiogram normal, Generalised tonic-clonic seizure, Laboratory test normal
Clinical narrative: I received my first dose of the Pfizer COVID-19 booster and had no immediate adverse reactions.  I received the original Pfizer vaccine (2 doses) in February and March of 2021 with no adverse reactions. On 11NOV2022 I experienced a tonic-clonic seizure lasting less than 5 minutes at approximately 0500 AM. I was diagnosed with generalized idiopathic epilepsy in January 2021 following a tonic-clonic seizure while sick with COVID-19. In March of 2022, I experience another tonic-clonic seizure while sick with COVID-19.  I have written an article on epileptiform discharges and seizures as a result of COVID-19 and its symptoms (breakdown of the blood-brain barrier, spike in fever, etc.) which highlights a correlation between the two illnesses. I believe that COVID-19 was essentially a catalyst for an underlying genetic marker that I carry (PRRT2 gene mutation) which set off the 3 seizures which I have had in last 23 months. While not easy to confirm that this was a true adverse reaction as a direct result of the booster vaccine, it seems too coincidental to ignore. Please reach out to me if there are any questions or concerns! Very Respectfully,
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 19 days beyond use date
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Vaccine given 16 days beyond use date
Age: 47.0
Sex: F
Vaccine: VARCEL
Symptoms: Dyspnoea, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: Reported  shortness of breath and big itchy red lump at vaccination site
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Bursitis, Magnetic resonance imaging, Pain in extremity
Clinical narrative: subacromial bursitis, severe arm and shoulder pain.
Age: 34.0
Sex: F
Vaccine: VARCEL
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat reported on 12/5/22
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 1/13/21  Pfizer  EL3248 dose 2 2/1/21  Pfizer  EL9265
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine adminsitered
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine adminsitered
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine adminsitered
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine adminsitered
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine administered
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine adminsitered
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: expired vaccine admnistered
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Agitation, Anticoagulant therapy, Asymptomatic COVID-19, Cerebral hypoperfusion, Cerebral infarction
Clinical narrative: Patient with 3 COVID vaccines who admitted and had COVID detected PCR found upon d/c planning.  Asymptomatic for COVID found during routine testing for facilty placement.  "86 year old patient with a history of paroxysmal atrial fibrillation, Parkinson's disease, and mild cognitive impairment presented with L sided weakness with suspected CVA involving the left parasagittal frontal lobe as visualized on CT Cerebral perfusion, showing critical hypoperfusion, with subsequent weakness in his right upper and right lower extremities. Suspect thromboembolic based on the location and distribution of the infarct. Neurology was consulted. It was deemed Eliquis failure, for which Neurology recommended transition to Xarelto, which the patient tolerated without complication. ASA was discontinued due to risk of bleed/hemorrhagic conversion while already on anticoagulation given his history of atrial fibrillation. The patient also demonstrated recurring agitation and confusion, and attempts at initiating pharmacotherapy were made with some success. By discharge, the patient was on a regimen of Seroquel 25 mg in the morning, Seroquel 50 mg in the early evening, and PRN haldol oral solution for breakthrough agitation. The morning dose to be administered at the discretion of the family, depending on striking a balance of agitation prevention and interactivity. The patient was found to be COVID positive on PCR screen, however he was asymptomatic. He was discharged home with family in stable condition."
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebrovascular accident, Condition aggravated, Confusional state, Embolism, Hemiparesis
Clinical narrative: Patient with 3 COVID vaccines who admitted and had COVID detected PCR found upon d/c planning.  Asymptomatic for COVID found during routine testing for facilty placement.  "86 year old patient with a history of paroxysmal atrial fibrillation, Parkinson's disease, and mild cognitive impairment presented with L sided weakness with suspected CVA involving the left parasagittal frontal lobe as visualized on CT Cerebral perfusion, showing critical hypoperfusion, with subsequent weakness in his right upper and right lower extremities. Suspect thromboembolic based on the location and distribution of the infarct. Neurology was consulted. It was deemed Eliquis failure, for which Neurology recommended transition to Xarelto, which the patient tolerated without complication. ASA was discontinued due to risk of bleed/hemorrhagic conversion while already on anticoagulation given his history of atrial fibrillation. The patient also demonstrated recurring agitation and confusion, and attempts at initiating pharmacotherapy were made with some success. By discharge, the patient was on a regimen of Seroquel 25 mg in the morning, Seroquel 50 mg in the early evening, and PRN haldol oral solution for breakthrough agitation. The morning dose to be administered at the discretion of the family, depending on striking a balance of agitation prevention and interactivity. The patient was found to be COVID positive on PCR screen, however he was asymptomatic. He was discharged home with family in stable condition."
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Perfusion brain scan abnormal, SARS-CoV-2 test positive, Treatment failure
Clinical narrative: Patient with 3 COVID vaccines who admitted and had COVID detected PCR found upon d/c planning.  Asymptomatic for COVID found during routine testing for facilty placement.  "86 year old patient with a history of paroxysmal atrial fibrillation, Parkinson's disease, and mild cognitive impairment presented with L sided weakness with suspected CVA involving the left parasagittal frontal lobe as visualized on CT Cerebral perfusion, showing critical hypoperfusion, with subsequent weakness in his right upper and right lower extremities. Suspect thromboembolic based on the location and distribution of the infarct. Neurology was consulted. It was deemed Eliquis failure, for which Neurology recommended transition to Xarelto, which the patient tolerated without complication. ASA was discontinued due to risk of bleed/hemorrhagic conversion while already on anticoagulation given his history of atrial fibrillation. The patient also demonstrated recurring agitation and confusion, and attempts at initiating pharmacotherapy were made with some success. By discharge, the patient was on a regimen of Seroquel 25 mg in the morning, Seroquel 50 mg in the early evening, and PRN haldol oral solution for breakthrough agitation. The morning dose to be administered at the discretion of the family, depending on striking a balance of agitation prevention and interactivity. The patient was found to be COVID positive on PCR screen, however he was asymptomatic. He was discharged home with family in stable condition."
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID positive
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Arthralgia, Asthenia, COVID-19, Chest X-ray normal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 11/30/2022 Discharge Date: 12/4/2022 COVID positive date: 11/30/2022 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] COVID [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE:    Patient is a 77 y.o. male with prior medical history of hypertension, ischemic cardiomyopathy, type 2 diabetes, hyperlipidemia, atrial fibrillation (on Eliquis), arthritis and iron deficiency anemia.  He presented to the hospital on 11/20/2022 for evaluation of weakness.  The patient fell /at home on 11/26/2022.  He was evaluated in the emergency department at that time and found to have a right femur fraction that was deemed inoperable.  The patient was instructed to weight bear as tolerated and follow up outpatient with Orthopedics.  The patient noted that he had more difficulty ambulating at home which got progressively worse over the past few days thus he proceeded to present back for evaluation on 11/30.   Endorses a cough and sputum production but notes that this has been ongoing for 3 weeks and not much different from his baseline.  Denies any known exposures to COVID-19 however did test COVID 19 positive in the emergency department. Physical therapy and occupational therapy consult were completed and recommended SAR.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Device breakage, Fall, Femur fracture, Gait disturbance
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 11/30/2022 Discharge Date: 12/4/2022 COVID positive date: 11/30/2022 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] COVID [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE:    Patient is a 77 y.o. male with prior medical history of hypertension, ischemic cardiomyopathy, type 2 diabetes, hyperlipidemia, atrial fibrillation (on Eliquis), arthritis and iron deficiency anemia.  He presented to the hospital on 11/20/2022 for evaluation of weakness.  The patient fell /at home on 11/26/2022.  He was evaluated in the emergency department at that time and found to have a right femur fraction that was deemed inoperable.  The patient was instructed to weight bear as tolerated and follow up outpatient with Orthopedics.  The patient noted that he had more difficulty ambulating at home which got progressively worse over the past few days thus he proceeded to present back for evaluation on 11/30.   Endorses a cough and sputum production but notes that this has been ongoing for 3 weeks and not much different from his baseline.  Denies any known exposures to COVID-19 however did test COVID 19 positive in the emergency department. Physical therapy and occupational therapy consult were completed and recommended SAR.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Joint injury, Limb injury, Pain in extremity, Plantar fasciitis, Productive cough
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 11/30/2022 Discharge Date: 12/4/2022 COVID positive date: 11/30/2022 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] COVID [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE:    Patient is a 77 y.o. male with prior medical history of hypertension, ischemic cardiomyopathy, type 2 diabetes, hyperlipidemia, atrial fibrillation (on Eliquis), arthritis and iron deficiency anemia.  He presented to the hospital on 11/20/2022 for evaluation of weakness.  The patient fell /at home on 11/26/2022.  He was evaluated in the emergency department at that time and found to have a right femur fraction that was deemed inoperable.  The patient was instructed to weight bear as tolerated and follow up outpatient with Orthopedics.  The patient noted that he had more difficulty ambulating at home which got progressively worse over the past few days thus he proceeded to present back for evaluation on 11/30.   Endorses a cough and sputum production but notes that this has been ongoing for 3 weeks and not much different from his baseline.  Denies any known exposures to COVID-19 however did test COVID 19 positive in the emergency department. Physical therapy and occupational therapy consult were completed and recommended SAR.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Walking aid user, X-ray abnormal, X-ray limb, X-ray of pelvis and hip abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider at Discharge: MD   Admission Date: 11/30/2022 Discharge Date: 12/4/2022 COVID positive date: 11/30/2022 PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] COVID [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE:    Patient is a 77 y.o. male with prior medical history of hypertension, ischemic cardiomyopathy, type 2 diabetes, hyperlipidemia, atrial fibrillation (on Eliquis), arthritis and iron deficiency anemia.  He presented to the hospital on 11/20/2022 for evaluation of weakness.  The patient fell /at home on 11/26/2022.  He was evaluated in the emergency department at that time and found to have a right femur fraction that was deemed inoperable.  The patient was instructed to weight bear as tolerated and follow up outpatient with Orthopedics.  The patient noted that he had more difficulty ambulating at home which got progressively worse over the past few days thus he proceeded to present back for evaluation on 11/30.   Endorses a cough and sputum production but notes that this has been ongoing for 3 weeks and not much different from his baseline.  Denies any known exposures to COVID-19 however did test COVID 19 positive in the emergency department. Physical therapy and occupational therapy consult were completed and recommended SAR.
Age: 95.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cardiac failure congestive, Chronic left ventricular failure, Condition aggravated, Cough
Clinical narrative: COVID+ 12/5/2022.  Vaccination status - pfizer x3 + pfizer BIVALENT BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: DO Admission Date: 12/5/2022 Discharge Date: Dec 7, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 12/06/2022 Unknown ? COVID-19 virus infection 12/05/2022 Yes ? Acute cystitis 12/05/2022 Yes ? Chronic diastolic congestive heart failure (HCC) 12/05/2022 Yes ? Persistent atrial fibrillation (HCC) 11/12/2021 Yes ? Primary hypertension 11/01/2021 Yes ? Stage 3a chronic kidney disease (HCC) 11/01/2021 Yes ? History of deep vein thrombosis (DVT) of lower extremity 11/01/2021 Yes ? History of pulmonary embolus (PE) 11/01/2021 Yes ? Presence of IVC filter   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Upper respiratory tract infection, unspecified type [J06.9] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE:   Pt is a 96 yr old F presented from PCP's office for worsening cough. She was recently started on Lisinopril and dose had been increased. Also known to recently have COVID infection on 10/6/22. Workup in the ED showed stable vitals, low procalcitonin, normal WBC, film array positive for COVID and UA concerning for UTI.    Pt complained of congestion, low grade fevers, couth and dysuria. Empirically started on IV Rocephin for UTI. She was symptomatically managed from her presumed re-infection of COVID given her nasal congestion, worsening cough (though this could also be secondary to Lisinopril). Her lisinopril was discontinued.   Patient did well in the hospital- did not require oxygen. PT recommended Home. Son requested COVID viral load but unfortunately, this test is not currently available per my discussion with the COVID team. Son wasn't convinced patient had re-infection with COVID. It is difficulty to determine however, given nasal congestion and cough - it would be in patient's best interest to continue to monitor closely.   Patient felt well to discharge home on 12/07/2022 in the care of her family. She is discharged home in stable condition. Patient and son requested starting Losartan - this was prescribed after discussion of risks/benefits and I recommended that they monitor blood pressures closely. COVID and VTE prevention added onto to discharge instructions